Bridgeway Capital Management’s Solid Biosciences SLDB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $480K | Buy |
98,531
+15,000
| +18% | +$73.1K | 0.01% | 784 |
|
|
2025
Q1 | $309K | Sell |
83,531
-19,100
| -19% | -$70.7K | 0.01% | 835 |
|
|
2024
Q4 | $411K | Buy |
102,631
+51,574
| +101% | +$206K | 0.01% | 856 |
|
|
2024
Q3 | $356K | Hold |
51,057
| – | – | 0.01% | 942 |
|
|
2024
Q2 | $289K | Hold |
51,057
| – | – | 0.01% | 973 |
|
|
2024
Q1 | $680K | Hold |
51,057
| – | – | 0.01% | 837 |
|
|
2023
Q4 | $313K | Buy |
51,057
+15,000
| +42% | +$92.1K | 0.01% | 1058 |
|
|
2023
Q3 | $90.9K | Buy |
36,057
+10,000
| +38% | +$25.2K | ﹤0.01% | 1244 |
|
|
2023
Q2 | $137K | Sell |
26,057
-8,629
| -25% | -$45.2K | ﹤0.01% | 1208 |
|
|
2023
Q1 | $164K | Buy |
34,686
+15,000
| +76% | +$71.1K | ﹤0.01% | 1136 |
|
|
2022
Q4 | $106K | Sell |
19,686
-1
| -0% | -$5 | ﹤0.01% | 1206 |
|
|
2022
Q3 | $138K | Hold |
19,687
| – | – | ﹤0.01% | 1216 |
|
|
2022
Q2 | $182K | Sell |
19,687
-6,666
| -25% | -$61.6K | ﹤0.01% | 1109 |
|
|
2022
Q1 | $474K | Buy |
26,353
+13,333
| +102% | +$240K | 0.01% | 950 |
|
|
2021
Q4 | $342K | Buy |
13,020
+10,587
| +435% | +$278K | 0.01% | 1070 |
|
|
2021
Q3 | $87K | Sell |
2,433
-6,127
| -72% | -$219K | ﹤0.01% | 1258 |
|
|
2021
Q2 | $470K | Sell |
8,560
-3,132
| -27% | -$172K | 0.01% | 1083 |
|
|
2021
Q1 | $970K | Hold |
11,692
| – | – | 0.02% | 874 |
|
|
2020
Q4 | $1.33M | Sell |
11,692
-3,066
| -21% | -$349K | 0.03% | 675 |
|
|
2020
Q3 | $449K | Buy |
14,758
+5,333
| +57% | +$162K | 0.01% | 939 |
|
|
2020
Q2 | $414K | Buy |
9,425
+5,560
| +144% | +$244K | 0.01% | 921 |
|
|
2020
Q1 | $139K | Buy |
3,865
+798
| +26% | +$28.7K | ﹤0.01% | 1136 |
|
|
2019
Q4 | $205K | Hold |
3,067
| – | – | ﹤0.01% | 1194 |
|
|
2019
Q3 | $476K | Buy |
+3,067
| New | +$476K | 0.01% | 976 |
|